Clinical Trials

Mustang Bio, Inc. is committed to the development of novel immunotherapies that extend and enhance the quality of life for patients suffering from cancer and other underserved therapeutic needs based on ground breaking Chimeric Antigen Receptor (CAR) research.  An integral part of achieving this goal is the conduct of robust and efficient clinical trials at the highest standards of quality attainable.

Information on Mustang Bio’s ongoing clinical trials in partnership with the City of Hope, including information for healthcare providers and patients interested in participating in any ongoing clinical trials, can be found at www.clinicaltrials.gov, or at the links for each specific trial: